Your browser doesn't support javascript.
loading
Impact of lysophosphatidylcholine on survival and function of UEA-1(+)acLDL (+) endothelial progenitor cells in patients with coronary artery disease.
Hong, Seong Hun; Jang, Hyun Hee; Lee, So Ra; Lee, Kyung Hye; Woo, Jong Shin; Kim, Jin Bae; Kim, Woo-Shik; Min, Byung Il; Cho, Ki Ho; Kim, Kwon Sam; Cheng, Xianwu; Kim, Weon.
Afiliación
  • Hong SH; Division of Cardiology, Kyung Hee University, Seoul, Republic of Korea.
Heart Vessels ; 30(1): 115-25, 2015 Jan.
Article en En | MEDLINE | ID: mdl-24510253
Lysophosphatidylcholine (LPC) generated from oxidized low-density lipoprotein by lipoprotein-associated phospholipase A2 plays a key role in plaque inflammation and vulnerability. Endothelial progenitor cells (EPCs) can repair injured endothelium and exert anti-inflammatory effects of vulnerable plaque. We study the impact and mechanisms of LPC on UEA-1 and acLDL binding EPCs (UEA-1(+)acLDL(+) EPCs). UEA-1(+)acLDL(+) EPCs from coronary artery disease (CAD) patients were cultured and exposed to LPC at different concentrations and different timepoints. We determined the significant concentration (40 µM). UEA-1(+)acLDL(+) EPCs were preincubated for 30 min with pravastatin (20 µM) with LY249002, a specific inhibitor of the Akt signaling pathway, and exposed for 24 h to LPC 40 µM. The survival, migration, adhesion, and proliferation of UEA-1(+)acLDL(+) EPCs were assessed. To examine the mechanisms of LPC toxicity and pravastatin effects, phosphorylated Akt and endothelial nitric oxide synthase (eNOS) levels and the ratio of Bcl-2/Bax protein expression were assessed. LPC induced apoptosis and impaired migration and adhesion of UEA-1(+)acLDL(+) EPCs significantly. The detrimental effects of LPC were attenuated by pravastatin. However, when UEA-1(+)acLDL(+) EPCs were pretreated with pravastatin and LY249002, a specific inhibitor of the Akt signaling pathway, simultaneously, the beneficial effects of pravastatin were abolished. Furthermore, LPC suppressed Akt and eNOS phosphorylation and increased Bcl-2/Bax expression. The effects of LPC on Akt/eNOS and Bcl-2/Bax activity were reversed by pravastatin. In conclusion, LPC inhibited UEA-1(+)acLDL(+) EPCs survival and impaired its functions, and these were attributable to inhibition of the Akt/eNOS and Bcl-2/Bax pathway. Pravastatin reversed the detrimental action of LPC. These findings suggest that LPC inhibition can be a possible strategy for CAD through EPC revitalization.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad de la Arteria Coronaria / Lisofosfatidilcolinas / Pravastatina / Lectinas de Plantas / Células Progenitoras Endoteliales / Lipoproteínas LDL Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Heart Vessels Asunto de la revista: CARDIOLOGIA Año: 2015 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad de la Arteria Coronaria / Lisofosfatidilcolinas / Pravastatina / Lectinas de Plantas / Células Progenitoras Endoteliales / Lipoproteínas LDL Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Heart Vessels Asunto de la revista: CARDIOLOGIA Año: 2015 Tipo del documento: Article